Rani Therapeutics Holdings, Inc. Annual Depreciation in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Rani Therapeutics Holdings, Inc. annual/quarterly Depreciation history and growth rate from 2020 to 2023.
  • Rani Therapeutics Holdings, Inc. Depreciation for the quarter ending March 31, 2022 was $111K, a 18.4% decline year-over-year.
  • Rani Therapeutics Holdings, Inc. annual Depreciation for 2023 was $800K, a 60% increase from 2022.
  • Rani Therapeutics Holdings, Inc. annual Depreciation for 2022 was $500K, unchanged from 2021.
  • Rani Therapeutics Holdings, Inc. annual Depreciation for 2021 was $500K, a 15.1% decline from 2020.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.